Novo Integrated SciencesNVOS
13F holders, Q4 2024 (December 31)1holders −15
1new positions
17sold out
$0.05avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Novo Integrated Sciences Inc. (NVOS) in their 13F filings, down 15 from Q3 2024. 1 opened new positions and 17 sold out. The largest holder was ACT Advisors, LLC. ($693).
- Company
- Novo Integrated Sciences Inc.
- CUSIP
- 67011T300
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $693 |
| Exits | 17 | $306K |
All 13F filers, Q3 2024 → Q4 2024: 13,358 shares bought and 1,090,154 shares sold, net −1,076,796 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| ACT Advisors, LLC. | 0.00% | New | 13,358 | $693 |
"% of holder's portfolio" is NVOS's weight in each manager's 13F, not the share of Novo Integrated Sciences Inc. the manager owns.